Amneal Pharmaceuticals, Inc. (AMRX) announced on Wednesday that it has received FDA approval for its Over the Counter Naloxone Hydrochloride or HCI Nasal Spray, USP, 4mg.
This nasal spray is designed to quickly counteract the effects of a life-threatening opioid emergency by interacting with opioid receptors to reverse or block opioid effects.
Manufactured in the U.S., Amneal's Naloxone HCI Nasal Spray is a generic version of the widely used OTC NARCAN HCI Nasal Spray.
Amneal's Naloxone HCI Nasal Spray is now accessible over the counter.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.